National MS Society Releases Recommendations for AHSCT-Bone Marrow Transplant for MS
November 12, 2020
November 12, 2020
NEW YORK, Nov. 12 (TNSJou) -- The National Multiple Sclerosis Society issued the following news:
The National Medical Advisory Committee of the National MS Society has written an article reviewing evidence related to the optimal use of autologous hematopoietic stem cell transplantation (aHSCT, commonly known as bone marrow transplants) for the treatment of specific types of relapsing multiple sclerosis. The committee's recommendations are now published (JAMA Neurology, online Octobe . . .
The National Medical Advisory Committee of the National MS Society has written an article reviewing evidence related to the optimal use of autologous hematopoietic stem cell transplantation (aHSCT, commonly known as bone marrow transplants) for the treatment of specific types of relapsing multiple sclerosis. The committee's recommendations are now published (JAMA Neurology, online Octobe . . .